UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

———————

FORM 8-K

———————

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~December~~April 618, ~~2023~~2025

———————

MediXall Group, Inc.

(Exact name of registrant as specified in its charter)

———————

Nevada	333-186282	33-0864127
(State or Other Jurisdiction	(Commission	(I.R.S. Employer
of Incorporation)	File Number)	Identification No.)

~~2598~~104 E.N ~~Sunrise~~4th ~~Blvd~~St., ~~Suite 2104~~Leesburg, ~~Fort Lauderdale,~~ Florida ~~33304~~34748

(Address of Principal Executive Office) (Zip Code)

(~~877~~800) ~~558~~381-~~7750~~1787

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
N/A	N/A	N/A

Indicate by check mark whether the registrant is an emerging growth company as defined in in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On ~~December~~April 618, ~~2023~~2025, the Board of Directors of MediXall Group, Inc. (the "Company") ~~accepted~~appointed the ~~written~~following ~~resignation of Noel Guillama~~ as ~~its~~members ~~interim~~of ~~Principal~~the ~~Financial~~Board ~~Officer~~of ~~and appointed~~Directors: ~~Shane~~Susan ~~Glavin~~Poniatowski, toGarth ~~replace~~Walker, ~~Mr.~~Gene ~~Guillama~~Shvedov.

~~Shane~~Ms. ~~Glavin~~Susan isPoniatowski brings extensive leadership, financial, and governance expertise to the ~~CEO~~Board, with over two decades of ~~Power~~experience ~~CFO~~as Trustee of The Poniatowski Trusts, where she oversaw compliance, investment due diligence, tax reporting, and beneficiary distributions for complex trusts. HeHer ~~founded~~background ~~Power~~includes executive management at TerraSonics, ~~CFO~~LLC, awhere ~~premier~~she ~~fractional~~led ~~CFO~~budgeting, ~~firm~~contract negotiations, inand ~~March~~IP ~~2021~~strategy, toas ~~help~~well ~~small~~as tobusiness ~~mid-size~~consulting ~~companies~~at ~~realize~~Arthur ~~the~~D. ~~enormous~~Little, advising on M&A, financial analysis, and ~~operational~~corporate ~~benefits~~restructuring. Additionally, Ms. Poniatowski served as an Adjunct Research Professor at UMass ~~that~~Lowell, ~~enterprise-level~~teaching ~~organizations~~business ~~expect~~and engineering economics, further demonstrating her strategic and analytical acumen. Her multidisciplinary experience ~~every~~in ~~day~~governance, finance, and operational oversight positions her as a valuable asset to the Board.

~~Shane~~Mr. isGene aShvedov ~~results-driven~~brings decades of executive ~~with~~leadership, ~~more~~financial ~~than~~expertise, 20and ~~years~~entrepreneurial acumen to the Board. As founder and CEO of ~~experience~~American Best Group, he scaled a logistics startup to $10M in ~~finance~~revenue before its successful sale, ~~accounting~~later serving as COO during its transition. Through AGS Insurance Group, LLC, he built and ~~operations~~managed ~~management~~a diversified portfolio of companies spanning insurance, trucking, and medical education. HeHis ~~has~~financial anleadership ~~MBA~~includes ~~from~~roles ~~Baker~~as Director of Finance at Cotelligent (NYSE: CGZ), where he overhauled accounting systems, managed IPO preparation, and led strategic planning, budgeting, and mergers/acquisitions due diligence. A Certified Public Accountant (Rutgers University, ~~located~~B.S. Accounting), he began his career in ~~Baldwin~~audit and ~~City~~tax at Goldstein Golub Kessler & Co., P.C. His blend of operational, financial, and governance experience, including ESOP/Profit ~~Kansas~~Sharing Plan administration and corporate restructuring, positions him as a valuable asset to the Board.

~~Prior~~Mr. toGarth ~~launching~~Walker ~~Power~~brings ~~CFO,~~a ~~Shane~~unique ~~developed~~combination ~~the~~of technical expertise, financial ~~Rock~~acumen, and ~~Evolve~~hands ~~programs,~~on ~~both~~investment ofexperience ~~which~~to ~~drove~~the ~~millions~~Board. ofAs ~~dollars~~a seasoned chemical engineer with a career at a major oil company, he developed rigorous analytical skills in ~~savings~~project feasibility, risk assessment, and complex operational evaluations. InBeyond ~~2019~~his corporate experience, Mr. ~~Shane~~Walker ~~was~~has ~~recognized~~built bya ~~both~~diversified ~~the~~investment ~~Kansas~~portfolio ~~City~~spanning ~~Business~~real estate (rental homes, apartment complexes), energy assets (oil royalties, ~~Journal~~wells), and ~~Bullhorn~~private ~~for~~lending ~~his~~(hard ~~ability~~money toloans). ~~identify~~This ~~significant~~entrepreneurial ~~operational~~background ~~inefficiency~~has ~~and~~provided ~~gaps~~him ~~and~~with ~~quickly~~deep, ~~implement~~practical ~~strategic~~insights ~~technology~~into capital allocation, tax optimization, and~~/or~~ ~~streamlining~~value ~~business~~creation ~~operations~~across multiple asset classes. His ability to bridge technical and financial perspectives, coupled ~~which~~with ~~significantly~~his ~~increased~~firsthand ~~revenue~~experience in both successful and ~~reduced~~challenging ~~company~~investment, ~~costs~~positions Mr. Walker to contribute meaningfully to the Board’s strategic and governance oversight.

~~Shane~~In ~~has~~addition, ~~been~~on April 18, 2025, the ~~CFO~~Board ~~and~~of ~~Chief~~Directors ~~Innovation~~accepted ~~Officer~~the resignations ~~for~~of ~~LaborMAX~~Travis ~~Staffing~~Jackson and ~~was~~John VPMarino, ~~Finance~~recognizing &their ~~Administration/Corporate~~contributions ~~Controller~~while ~~for~~taking ~~Midwest~~deliberate ~~Pacific~~steps ~~Rail~~to ~~Net~~sharpen &the ~~Logistics~~Company’s strategic focus and governance.

Mr. Jackson’s resignation reflects his commitment to prioritizing his role as CEO, enabling him to dedicate his full attention to evaluating strategic opportunities for the Company and presenting unbiased recommendations to the Board. This separation of leadership and governance roles underscores the Company’s commitment to rigorous oversight and independent decision-making.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.		Description

104		Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	MediXall Group Inc.
Dated: December 12, 2023	By:	/s/ Travis Jackson
Dated: April 23, 2025	By:	/s/ Travis Jackson
	Name:	Travis Jackson
	Title:	Chief Executive Officer

Filing Compare · MediXall Group, Inc.